<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang F</submitter><funding>Thomas Jefferson University</funding><funding>NHLBI NIH HHS</funding><funding>NIMH NIH HHS</funding><funding>National Institute of Mental Health</funding><funding>National Institutes of Health</funding><pagination>4434-4446</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5602903</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>31(10)</volume><pubmed_abstract>The amyloid precursor protein (APP) has long been appreciated for its role in Alzheimer's disease (AD) pathology. However, less is known about the physiologic function of APP outside of AD. Particularly, whether and how APP may regulate functions of cell surface receptors, including GPCRs, remains largely unclear. In this study, we identified a novel direct interaction between APP and the α&lt;sub>2A&lt;/sub>-adrenergic receptor (α&lt;sub>2A&lt;/sub>AR) that occurs at the intracellular domains of both proteins. The APP interaction with α&lt;sub>2A&lt;/sub>AR is promoted by agonist stimulation and competes with arrestin 3 binding to the receptor. Consequently, the presence of APP attenuates α&lt;sub>2A&lt;/sub>AR internalization and desensitization, which are arrestin-dependent processes. Furthermore, in neuroblas</pubmed_abstract><journal>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</journal><pubmed_title>The amyloid precursor protein modulates α&lt;sub>2A&lt;/sub>-adrenergic receptor endocytosis and signaling through disrupting arrestin 3 recruitment.</pubmed_title><pmcid>PMC5602903</pmcid><funding_grant_id>R01 HL121206</funding_grant_id><funding_grant_id>MH081917</funding_grant_id><funding_grant_id>R21 HL127599</funding_grant_id><funding_grant_id>R01 MH081917</funding_grant_id><pubmed_authors>Zhang F</pubmed_authors><pubmed_authors>Gannon M</pubmed_authors><pubmed_authors>Zhou L</pubmed_authors><pubmed_authors>Jiao K</pubmed_authors><pubmed_authors>Wang Q</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>The amyloid precursor protein modulates α&lt;sub>2A&lt;/sub>-adrenergic receptor endocytosis and signaling through disrupting arrestin 3 recruitment.</name><description>The amyloid precursor protein (APP) has long been appreciated for its role in Alzheimer's disease (AD) pathology. However, less is known about the physiologic function of APP outside of AD. Particularly, whether and how APP may regulate functions of cell surface receptors, including GPCRs, remains largely unclear. In this study, we identified a novel direct interaction between APP and the α&lt;sub>2A&lt;/sub>-adrenergic receptor (α&lt;sub>2A&lt;/sub>AR) that occurs at the intracellular domains of both proteins. The APP interaction with α&lt;sub>2A&lt;/sub>AR is promoted by agonist stimulation and competes with arrestin 3 binding to the receptor. Consequently, the presence of APP attenuates α&lt;sub>2A&lt;/sub>AR internalization and desensitization, which are arrestin-dependent processes. Furthermore, in neuroblas</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Oct</publication><modification>2025-04-05T14:31:20.645Z</modification><creation>2019-03-26T23:57:51Z</creation></dates><accession>S-EPMC5602903</accession><cross_references><pubmed>28646018</pubmed><doi>10.1096/fj.201700346R</doi><doi>10.1096/fj.201700346r</doi></cross_references></HashMap>